Theta Deep Brain Stimulation for Cognitive Impairment in Parkinson's Disease
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
Recruiting
N/AInterventional Study
Parkinson DiseaseCognitive Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
27 (estimated)
Sponsor
University of British Columbia · Other
Who this trial is looking for
This trial is looking for people with Parkinson's disease who have received a type of brain stimulation called STN DBS. Participants will need to have imaging done before and after their surgery and be at least 3 months post-operation.
Are You a Good Fit for This Trial?
You may be able to join if
I have an STN DBS device
I have had pre- and post-operative imaging
I am at least 3 months post-operative
You may not be able to join if
I am unable to complete the cognitive task due to language barriers or dementia
I have significant complications from the DBS
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and \> 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contribu…
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and \> 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contributing factor is dysfunction in subthalamic-cortical loops.
The subthalamic nucleus (STN) receives input from distributed regions of the cortex, forming partially segregated parallel networks with sensorimotor regions, associative (cognitive) cortical regions, and limbic cortical regions. These subthalamic-cortical networks are thought to play a domain general role in inhibitory control, which is a fundamental mechanism underlying flexible behavior across motor, cognitive, and affective domains. Information processing in these subthalamic-cortical networks is expressed through oscillatory activity within distinct frequency bands. For example, communication between the STN and prefrontal regions involved in executive function is thought to occur through coherence in the theta (4-8 Hz) frequency band. As a result of these observations, stimulation of the STN at a theta frequency has been investigated as a method of modulating cognitive processes.
Theta stimulation of the STN has been shown to enhance coherence in subthalamic-cortical networks, facilitating information processing and modulating behavior. For example, a recent study demonstrated that theta stimulation of the STN improved working memory performance in PD subjects, while no effect was seen for other frequency bands. The authors performed a post-hoc analysis and found that the effect may be mediated by connectivity between the stimulated STN region and the right dorsolateral prefrontal cortex (DLPFC). While these studies have demonstrated proof of principle, they are limited by small sample sizes and post-hoc analyses assessing the relationship between stimulation location and outcomes. Further research is needed to directly test the hypothesis that theta stimulation of the STN can improve executive control in PD patients by modulating associative STN circuitry.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Those with STN DBS devices
* Those with pre- and post-operative imaging
* Those that are at least 3 months post-operative
Exclusion Criteria:
* Those unable to complete the cognitive task (due to language barriers or dementia)
* Those with significant DBS complications
Inclusion Criteria:
* Those with STN DBS devices
* Those with pre- and post-operative imaging
* Those that are at least 3 months post-operative
Exclusion Criteria:
* Those unable to complete the cognitive task (due to language barriers or dementia)
* Those with significant DBS complications
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.